Stay updated on Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', indicating the study is not enrolling any more participants. Additional navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions/Treatment header formatting plus a revision label update (v3.6.0) were applied.
    Difference
    0.4%
    Check dated 2026-06-13T04:41:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page shows a new deployment revision number, updating from v3.5.4 to v3.5.5. This change does not affect the study details or other visible content on the page.
    Difference
    0.1%
    Check dated 2026-06-05T21:44:14.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 at the bottom, replacing Revision: v3.5.3, indicating a recent site update or release without modifying the study content.
    Difference
    0.1%
    Check dated 2026-05-15T14:23:57.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The webpage’s footer revision version is updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:25:51.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:38.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:22:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.